Project Search Results

Select

Research Categorization

Operator
Operator

Project Details

Operator
Operator

Contact Researcher and Awardee Organization

Operator
Operator

Funding Organization

Operator
Operator
Operator
Operator
Displaying 1 - 10 of 16 Clinical Trials
ID/Name Source Type
A Cardiac Safety Study of Galantamine in the Treatment of Alzheimer's Disease.
NCT00309725 clinicaltrials.gov Clinical Trial
A Follow-up Study to Assess Safety and Tolerability of Galantamine Treatment in Individuals With Mild Cognitive Impairment
NCT00240695 clinicaltrials.gov Clinical Trial
A Long-Term Safety Extension of Studies ABE4869g and ABE4955g in Participants With Mild to Moderate Alzheimer's Disease Treated With Crenezumab
NCT01723826 clinicaltrials.gov Clinical Trial
A Pilot Study to Explore the Safety and Tolerability of Galantamine HBr in the Treatment of Pick Complex/Frontotemporal Dementia
NCT00416169 clinicaltrials.gov Clinical Trial
A Placebo-controlled Trial to Evaluate the Safety and Efficacy of Galantamine in the Treatment of Vascular Dementia
NCT00035191 clinicaltrials.gov Clinical Trial
A Study of Crenezumab in Participants With Mild to Moderate Alzheimer Disease
NCT02353598 clinicaltrials.gov Clinical Trial
A Study of RO7105705 in Healthy Participants and Participants With Mild-to-Moderate Alzheimer's Disease
NCT02820896 clinicaltrials.gov Clinical Trial
A Study of the Safety and Effectiveness of Two Doses of Galantamine Versus Placebo in the Treatment of Patients With Alzheimer's Disease
NCT00253201 clinicaltrials.gov Clinical Trial
A Study of the Safety, Pharmacokinetics, Pharmacodynamics, and Immunogenicity of Anti-Abeta (MABT5102A) in Patients With Alzheimer's Disease
NCT00736775 clinicaltrials.gov Clinical Trial
A Study to Evaluate the Efficacy and Safety of Galantamine in Patients With Mild Cognitive Impairment
NCT00236431 clinicaltrials.gov Clinical Trial